NCCN-protocol care · 45-minute detailed consultations · ArogyaSri, CGHS & cashless insurance accepted · Free second opinion
1800 202 8726
Common Questions · Reviewed by CION Oncologists · NABH Accredited

What Age Does Endometrial Cancer Actually Affect?

Mostly after the menopause. Incidence rises through the fifties, peaks in the sixties, and is uncommon before forty-five — so if you are in your thirties, age is genuinely reassuring. But there is one specific exception, and it accounts for most of the cases that do occur young: years of absent or very infrequent periods, usually from polycystic ovary syndrome, particularly alongside excess weight. Separately, Lynch syndrome causes a disproportionate share of young cases. This page covers both audiences — the woman wanting to know whether this is a disease of her age group, and the younger woman wanting to know whether she can stop worrying.

  • Peaks in the sixties — and rises steadily from around the menopause
  • Uncommon before forty-five — and genuinely rare before forty
  • One combination changes that — years without periods, plus excess weight
  • Lynch syndrome presents younger — and is worth considering when it does
4.8 · 1,000+ Google reviews · 15,000+ patients treated
Same-Week Appointments

Wondering Whether Your Age Protects You?

₹950   Today: FREE  ·  Consultation with a woman doctor on request

Assessed on your cycles and risk factors, not just your age
Bleeding investigated rather than attributed to youth
Confidential. No commitment to start treatment.
or
Call 18002028726
17+
Cancer Specialists
on Panel
35+
Centres
Across India
15,000+
Patients
Treated
4.8★
Google Rating
(800+ reviews)

The Picture, by Age Group

Broad rather than precise, because what matters practically is the shape of the distribution and where the exceptions sit.

AgeHow likelyWhat matters at this age
Under 30 Rare. Essentially confined to women with long-standing anovulation or Lynch syndrome. Heavy or absent periods still warrant addressing, for fertility and for endometrial protection.
30–40 Uncommon. The exception group matters here: years of absent periods with PCOS and excess weight. See bleeding in younger women.
40–50 Rising. Perimenopausal irregularity is expected and is exactly when real problems get dismissed. Over 45 with heavy or persistently irregular bleeding, the lining should be assessed. See bleeding in perimenopause.
50–60 Common. Around and after the menopause, any bleeding becomes unambiguous. A single episode warrants assessment. See postmenopausal bleeding.
60–70 Peak incidence. The core age group. Bleeding here is the classic presentation and should never be attributed to age itself.
Over 70 Still common. And a group where symptoms are more likely to be under-reported, and where non-endometrioid types are proportionally more frequent. See Type 2 endometrial cancer.

The row that causes most harm is 40–50. Cycles are genuinely erratic during the menopausal transition, so abnormal bleeding is easy to normalise — by the woman and sometimes by her doctor. This is also the age at which incidence begins climbing. Guidance recommends assessing the endometrium over 45 with heavy or persistently irregular bleeding, and it is worth knowing that.

Did You Know? Age is a proxy for something else, which is why it can be misleading. What actually accumulates with age is exposure — years of oestrogen acting on the lining of the womb, and the years after the menopause when fat tissue keeps producing oestrogen with no ovulation and therefore no progesterone at all to oppose it. A woman of sixty-five has had decades of that. But a woman of thirty-two who has bled twice a year since her teens, and carries excess weight, has also had years of unopposed exposure — compressed differently but genuinely accumulated. That is why the exception exists and why it takes the shape it does. Sources: SEER (Surveillance, Epidemiology and End Results) Program registry data, US National Cancer Institute; NCCN Clinical Practice Guidelines in Oncology — Uterine Neoplasms; ICMR National Cancer Registry Programme.
12+ Centres in Hyderabad · Pick yours

CION cancer care is closer than you think.

We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.

Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.

Help me pick the right centre

The Exception, in Detail

If you are under forty-five and worried, this is the section that determines whether that worry is warranted.

  • The combination is years of absent or very infrequent periods, plus excess weight. Not one or the other — the two compound. Absent periods mean no progesterone; excess weight means extra oestrogen. Both at once, sustained over years, is the mechanism.
  • It is the absence of bleeding that is the signal, not its presence. A woman with irregular but reasonably frequent periods is at least shedding her lining. A woman who bleeds twice a year is not, and that is the risk. This inversion catches people out.
  • PCOS is the usual underlying cause. Which is common, closely linked to insulin resistance, and highly prevalent in this region. See PCOS and endometrial cancer.
  • Lynch syndrome is the other route. An inherited fault in DNA repair, causing endometrial cancer at younger ages and frequently as the first cancer. A family pattern of bowel and womb cancer is the clue. See Lynch syndrome.
  • And early diagnosis matters especially here. Because fertility-sparing treatment is only possible for early, low-grade disease confined to the lining. A young woman diagnosed promptly may keep her uterus; one diagnosed two years later frequently cannot. See endometrial cancer and fertility.

Young, With Long Gaps Between Periods?

That is the specific combination worth discussing — for endometrial protection as much as for fertility.

or
Call 18002028726
Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Dr. Naresh Gundu
Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile
Dr. C. Raghavendra Reddy
Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile
Dr. Bharati Devi Gorantla
Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile
Dr. Owais Mohammed
Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile
Dr. T. Raghavender Reddy
Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile
Dr. N. Kiranmayee
Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile
Dr. Muralidhar Muddusetty
Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile
Dr. Raghavendra Naik
Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Mohammed  Imaduddin
Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile
Dr. Vinay Mamidala
Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile
Dr. Paila Gowri Naidu
Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile
Dr. Venkata Sushma P
Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile
Dr. Kirti Ranjan Mohanty
Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile
Dr. Gangadhar Vajrala
Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile
Dr. Basudev Pokhrel
Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile
Dr. Mohammed Imran
Interventional Radiologist

Dr. Mohammed Imran

View Profile
Dr. Vajja Sandeep Kumar
Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile
Dr. Sridhar Kamani
Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Age Is Reassuring. Your Cycle History May Not Be.

Years without periods is the one thing that changes the picture for a younger woman.

What Your Age Does and Does Not Tell You

Age is useful information and it is not a verdict in either direction.

Being young is genuinely reassuring

Not merely a platitude. Endometrial cancer before forty is rare, and a woman in her twenties or thirties with abnormal bleeding almost certainly has something else — hormonal contraception settling in, a pregnancy-related cause, infection, a thyroid problem, a bleeding disorder, fibroids or a polyp. It is reasonable for a doctor to work through those first, and reasonable for you to be reassured by your age. The exception is specific rather than general.

But it does not exclude anything

Age shifts probability; it does not close a question. If you have had years of absent or very infrequent periods, particularly with excess weight or PCOS, or if there is a family pattern of bowel and womb cancer, then your age carries less weight than it otherwise would. In that situation it is reasonable to ask for the uterine lining to be assessed rather than accepting reassurance based on age alone.

Being older does not mean bleeding is expected

The mirror error, and a more dangerous one. Bleeding after the menopause is never normal at any age, and attributing it to being older is precisely how late diagnoses happen. A single episode of light brown spotting in a woman of seventy-five warrants the same assessment as in a woman of fifty-five. Age is a reason to take it more seriously, not less.

And symptoms get under-reported with age

Older women are less likely to report gynaecological symptoms, for reasons ranging from embarrassment to assuming such things no longer matter to difficulty accessing appointments. If you are supporting an older relative, asking directly about bleeding is worth doing — it is frequently not volunteered.

Want Your Risk Assessed Properly?

Age, cycle history, weight and family history read together — which tells you far more than age alone. The opinion is free.

or
Call 18002028726

Why Incidence Rises With Age

The pattern follows from the mechanism, and understanding it explains why the exception takes the shape it does.

  • Exposure accumulates. This is a disease of cumulative oestrogen stimulation, so decades of it produce more risk than years of it. Age is a proxy for total exposure.
  • The brake disappears at menopause. No ovulation means no progesterone at all — permanently, rather than intermittently as in an anovulatory cycle. From that point onward, whatever oestrogen is present is entirely unopposed.
  • And fat becomes the main oestrogen source. After the ovaries stop, adipose tissue is the dominant remaining producer. So weight matters more after the menopause, not less — at exactly the age when this cancer is commonest. See reducing your risk after menopause.
  • The non-endometrioid types skew older still. Serous and clear cell carcinomas typically arise in older postmenopausal women on a thin lining, and are not oestrogen-driven at all — which is why a slim older woman with no risk factors is not immune.

For the fuller treatment of how age interacts with the other risk factors, see age and endometrial cancer risk.

Why Age Alone Is a Poor Assessment

It is the strongest single predictor and it misses exactly the group most likely to be dismissed.

45-minute consultations

Long enough to go through the scan, the report and the options properly — with a woman doctor available on request at every location.

Scan and biopsy in one visit

Transvaginal ultrasound and outpatient endometrial biopsy done in the same appointment, so the diagnostic question is settled in days, not weeks.

Fertility taken seriously

For younger women who want to conceive, fertility-sparing treatment with intensive surveillance is a recognised path — and one we discuss properly before proposing surgery.

Lynch counselling built in

Where testing suggests an inherited cause, genetic counselling is arranged rather than mentioned, and the implications for your family are explained to you.

Second opinions welcomed, not resented

Bring the reports you already have. If the plan you were given elsewhere is the right one, we will tell you so.

Decisions for healing, not billing

No unnecessary tests, and no treatment proposed that the tumour board has not agreed is the right one for your stage and grade.

Take The Next Step

Bleeding After Menopause Is Never Age-Appropriate

At seventy-five as much as at fifty-five. It is always worth investigating.

Real Stories. Real Voices.

15,000+ patients chose CION. Hear from them directly.

These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.

4.8★800+ Google reviews
50+video testimonials
15,000+patients treated

Successful Chemotherapy Done by Dr. C Raghavendra Reddy

Watch video →

Surgery, Chemo & Radiation Done by Dr. Imaduddin, Dr. Vinay, Dr. Owais, Dr. Kirti

Watch video →

Successful Radical Thymectomy Done by Dr. Mohammed Imaduddin & Dr. Vinay Mamidala

Watch video →

Successful Surgery Done by Dr. Rajender Byshetty

Watch video →

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →

Successful Chemo & Surgery Done by Dr. Imad, Dr. Vinay, Dr. Owais & Dr. Raghavendra

Watch video →

Successful Chemo & Radiation Done by Dr. Owais Mohammed & Dr. Kirti Ranjan Mohanty

Watch video →

Successful Breast Cancer Surgery Done by Dr. Imaduddin Mohammed & Dr. Vinay Mamidala

Watch video →

Successful Chemotherapy Done by Dr. Bharati Devi Gorantla

Watch video →

Successful Chemo & Surgery Done by Dr. Owais Mohammed & Dr. Imaduddin Mohammed

Watch video →

Successful Chemotherapy Done by Dr. Gundu Naresh

Watch video →

Successful Bone Marrow Transplantation - Neuroblastoma

Watch video →

Successful Surgery & Chemo - Carcinoma of Caecum

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Chemotherapy

Watch video →

Successful Surgery by Dr. Mohammed Imaduddin

Watch video →

Successful Bone Marrow Transplantation

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Oral chemotherapy & mastectomy surgery

Watch video →

Successful Chemotherapy

Watch video →

Successful Buccal Mucosa Surgery

Watch video →

Successful Complex Surgery Mandibulectomy Reconstruction

Watch video →
Common questions

Age & Endometrial Cancer — Frequently Asked Questions

What age is endometrial cancer most common?

It is predominantly a postmenopausal disease. Incidence rises through the fifties, peaks in the sixties, and remains substantial into the seventies. It is uncommon before forty-five and genuinely rare before forty. The pattern follows directly from the mechanism: this is a cancer of cumulative oestrogen exposure, and after the menopause there is no ovulation and therefore no progesterone at all to oppose whatever oestrogen remains — which, in a woman carrying excess weight, is produced by fat tissue. That is why weight matters more after the menopause rather than less, at exactly the age when this cancer is commonest.

Can a woman in her thirties get endometrial cancer?

It is uncommon, and when it does happen it is concentrated in two specific groups rather than occurring randomly. The larger group is women with years of absent or very infrequent periods, usually from polycystic ovary syndrome, particularly combined with excess weight — because no ovulation means no progesterone while fat tissue adds oestrogen, so unopposed exposure accumulates despite the young age. The other is women with Lynch syndrome, an inherited fault in DNA repair, in whom endometrial cancer occurs younger and is frequently the first cancer. Outside those groups, being in your thirties is genuinely reassuring.

I am under 45 with abnormal bleeding. Should I be worried?

Probably not about cancer specifically, and the bleeding still deserves assessment on its own terms. In your age group, abnormal bleeding is far more likely to be caused by hormonal contraception, a pregnancy-related cause, infection, thyroid problems, an undiagnosed bleeding disorder, fibroids or a polyp — all of which are worth identifying and most of which are treatable. The situation in which cancer becomes a genuine consideration is years of absent or very infrequent periods, particularly alongside excess weight or PCOS, or a family history of bowel and womb cancer. In that case, ask for the uterine lining to be assessed rather than accepting reassurance based on age.

Is bleeding after menopause more normal as you get older?

No — and this is the more dangerous of the two age-related errors. Bleeding after the menopause is never normal at any age, and attributing it to being older is precisely how late diagnoses occur. A single episode of light brown spotting in a woman of seventy-five warrants exactly the same assessment as in a woman of fifty-five. If anything, older age is a reason to take it more seriously, since incidence remains high and the non-endometrioid subtypes, which behave more aggressively, are proportionally more frequent in older women. Symptoms are also under-reported with age, so if you are supporting an older relative, ask directly.

Does age affect what treatment I would have?

It can, though less than people expect. The treatment is determined chiefly by the pathology — stage, grade, histological type and molecular group — rather than by age itself. Where age matters is at the margins: fertility-sparing treatment is only relevant for younger women, and only for early low-grade disease confined to the lining, which is one reason prompt diagnosis matters so much in that group. Whether to remove the ovaries is a genuine decision before the menopause and rarely debated after it. And in older women, general fitness and other medical conditions may influence how much treatment is appropriate.

Medical disclaimer: This page describes the age distribution of endometrial cancer and is reviewed by a CION oncologist, drawing on SEER registry data, ICMR National Cancer Registry Programme reports and current NCCN guidance. It describes patterns at a population level and does not predict individual risk. Age shifts probability but does not exclude the diagnosis. Any bleeding after the menopause should be assessed promptly regardless of age, and abnormal bleeding in a younger woman with long-standing absent periods warrants assessment of the endometrium.

Explore more

Explore All Endometrial Cancer Topics

Browse our complete library of endometrial (uterine) cancer guides — covering symptoms, risk factors, Lynch syndrome, diagnosis, precancer, types and staging, treatment, fertility, survival, survivorship and cost in Hyderabad.

Call now Book free consultation